EssilorLuxottica Société anonyme (ESLOY)
USD 139.72
(2.99%)
USD 139.72
(2.99%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 3.17 Billion EUR | 2.31% |
| 2022 | 3.15 Billion EUR | 35.73% |
| 2021 | 2.32 Billion EUR | 414.6% |
| 2020 | 452 Million EUR | -73.06% |
| 2019 | 1.67 Billion EUR | 23.56% |
| 2018 | 1.35 Billion EUR | 26.44% |
| 2017 | 1.07 Billion EUR | -12.68% |
| 2016 | 1.23 Billion EUR | 3.97% |
| 2015 | 1.18 Billion EUR | -3.19% |
| 2014 | 1.22 Billion EUR | 44.96% |
| 2013 | 843 Million EUR | 1.36% |
| 2012 | 831.71 Million EUR | 21.76% |
| 2011 | 683.09 Million EUR | 10.45% |
| 2010 | 618.47 Million EUR | 11.39% |
| 2009 | 555.21 Million EUR | 7.91% |
| 2008 | 514.53 Million EUR | 1.97% |
| 2007 | 504.58 Million EUR | 9.73% |
| 2006 | 459.85 Million EUR | 16.82% |
| 2005 | 393.63 Million EUR | -2.55% |
| 2004 | 403.94 Million EUR | 10.71% |
| 2003 | 364.85 Million EUR | 7.13% |
| 2002 | 340.58 Million EUR | 9.65% |
| 2001 | 310.59 Million EUR | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | 971.5 Million EUR | -1.37% |
| 2024 Q1 | 985 Million EUR | -26.49% |
| 2023 Q4 | 1.34 Billion EUR | 84.7% |
| 2023 FY | 3.23 Billion EUR | 2.31% |
| 2023 Q1 | 909 Million EUR | -37.7% |
| 2023 Q2 | 1.89 Billion EUR | 107.92% |
| 2023 Q3 | 725.5 Million EUR | -61.61% |
| 2022 Q2 | 1.78 Billion EUR | 109.0% |
| 2022 FY | 3.15 Billion EUR | 35.73% |
| 2022 Q1 | 856 Million EUR | -28.79% |
| 2022 Q3 | 714.5 Million EUR | -60.06% |
| 2022 Q4 | 1.45 Billion EUR | 104.2% |
| 2021 Q3 | 474 Million EUR | -63.87% |
| 2021 FY | 2.32 Billion EUR | 414.6% |
| 2021 Q1 | 649.5 Million EUR | -32.13% |
| 2021 Q2 | 1.31 Billion EUR | 102.0% |
| 2021 Q4 | 1.2 Billion EUR | 153.59% |
| 2020 FY | 452 Million EUR | -73.06% |
| 2020 Q1 | -102 Million EUR | -110.6% |
| 2020 Q2 | -238 Million EUR | -133.33% |
| 2020 Q3 | 324 Million EUR | 236.13% |
| 2020 Q4 | 957 Million EUR | 195.37% |
| 2019 Q3 | 473.5 Million EUR | -58.06% |
| 2019 FY | 1.67 Billion EUR | 23.56% |
| 2019 Q2 | 1.12 Billion EUR | 107.16% |
| 2019 Q1 | 545 Million EUR | 101.11% |
| 2019 Q4 | 962 Million EUR | 103.17% |
| 2018 Q1 | 485 Million EUR | -3.19% |
| 2018 Q3 | 271 Million EUR | -44.12% |
| 2018 Q4 | 271 Million EUR | 0.0% |
| 2018 FY | 1.35 Billion EUR | 26.44% |
| 2018 Q2 | 485 Million EUR | 0.0% |
| 2017 Q3 | 501 Million EUR | 49.33% |
| 2017 Q2 | 335.5 Million EUR | 0.0% |
| 2017 Q1 | 335.5 Million EUR | 7.88% |
| 2017 FY | 1.07 Billion EUR | -12.68% |
| 2017 Q4 | 501 Million EUR | 0.0% |
| 2016 Q2 | 326 Million EUR | 0.0% |
| 2016 FY | 1.23 Billion EUR | 3.97% |
| 2016 Q4 | 311 Million EUR | 0.0% |
| 2016 Q3 | 311 Million EUR | -4.6% |
| 2016 Q1 | 326 Million EUR | 10.14% |
| 2015 Q4 | 296 Million EUR | 0.0% |
| 2015 Q2 | 311.5 Million EUR | 0.0% |
| 2015 Q1 | 311.5 Million EUR | -5.89% |
| 2015 FY | 1.18 Billion EUR | -3.19% |
| 2015 Q3 | 296 Million EUR | -4.98% |
| 2014 Q3 | 331 Million EUR | 97.61% |
| 2014 FY | 1.22 Billion EUR | 44.96% |
| 2014 Q1 | 167.5 Million EUR | -18.29% |
| 2014 Q4 | 331 Million EUR | 0.0% |
| 2014 Q2 | 167.5 Million EUR | 0.0% |
| 2013 Q1 | 227.5 Million EUR | 0.0% |
| 2013 Q2 | 227.5 Million EUR | 0.0% |
| 2013 Q3 | 205 Million EUR | -9.89% |
| 2013 Q4 | 205 Million EUR | 0.0% |
| 2013 FY | 843 Million EUR | 1.36% |
| 2012 FY | 831.71 Million EUR | 21.76% |
| 2011 FY | 683.09 Million EUR | 10.45% |
| 2010 FY | 618.47 Million EUR | 11.39% |
| 2009 FY | 555.21 Million EUR | 7.91% |
| 2008 FY | 514.53 Million EUR | 1.97% |
| 2007 FY | 504.58 Million EUR | 9.73% |
| 2006 FY | 459.85 Million EUR | 16.82% |
| 2005 FY | 393.63 Million EUR | -2.55% |
| 2004 FY | 403.94 Million EUR | 10.71% |
| 2003 FY | 364.85 Million EUR | 7.13% |
| 2002 FY | 340.58 Million EUR | 9.65% |
| 2001 FY | 310.59 Million EUR | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| American Medical Technologies Inc. | 1.16 Million USD | -272700.673% |
| Ansell Limited | 129.3 Million USD | -2356.303% |
| Ansell Limited | 129.3 Million USD | -2356.303% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 31.13 Million USD | -10099.694% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | -1.59 Million USD | 199134.782% |
| Psykey, Inc. | -797.5 Thousand USD | 398342.517% |
| ConvaTec Group Plc | 262.7 Million USD | -1108.984% |
| ConvaTec Group Plc | 262.7 Million USD | -1108.984% |
| Encision Inc. | -640.78 Thousand USD | 495743.611% |
| Golden Valley Development, Inc | -141.81 Thousand USD | 2239716.388% |
| Hear AtLast Holdings, Inc. | -109.93 Thousand USD | 2889211.253% |
| Innovative MedTech Inc. | -4.27 Million USD | 74408.459% |
| LifePoint, Inc. | -7.49 Million USD | 42473.628% |
| Medite Cancer Diagnostics, Inc. | -6.48 Million USD | 49112.346% |
| Paradigm Medical Industries, Inc. | 330 Thousand USD | -962324.242% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | -122.89 Thousand USD | 2584525.096% |
| Reflect Scientific, Inc. | -467.27 Thousand USD | 679781.046% |
| SmileDirectClub, Inc. | -241.15 Million USD | 1416.99% |
| Sector 10, Inc. | -39.84 Thousand USD | 7971187.24% |
| Shandong Weigao Group Medical Polymer Company Limited | 319.6 Million USD | -893.721% |
| SheerVision, Inc. | 155.72 Thousand USD | -2039379.599% |
| United Health Products, Inc. | -2.42 Million USD | 130986.007% |
| Vasamed, Inc. | 4.74 Million USD | -66871.694% |
| Wearable Health Solutions, Inc. | -2.29 Million USD | 138539.616% |
| Yubo International Biotech Limited | -1.2 Million USD | 263619.697% |